Milei Moneda investors eye profits as presale outshines Injective, Cardano

Disclosure: This article does not represent investment advice. The content and materials featured on this page are for educational purposes only.

Milei Moneda’s (MEDA) fixed profit draws INJ and Cardano investors to its ongoing presale.

Injective continues to battle bearish trends as INJ loses on monthly and weekly returns. Cardano’s RSI and recent performances give investors reasons to doubt.

It has been a lacklustre few weeks for some of the top altcoins in the crypto market, especially Injective (INJ) and Cardano (ADA).

INJ and ADA investors are growing increasingly frustrated by both coins’ downward trends on the price charts, and they are now trooping to Milei Moneda (MEDA), a new cryptocurrency ICO that has found its way to the top ICO list with a guaranteed 100% ROI.

Investors dump INJ at the back of continuous fall

Following the implementation of Injective’s testnet, Injective has recently announced the launch of its Ionic upgrade on its Injective bridge, according to reports from various crypto news outlets. The upgrade would allow INJ users to shuttle between different blockchains with ease.

Apparently, the Ionic upgrade positions Injective as one of the best DeFi projects in the crypto-verse. However, the story is not entirely the same as that of INJ’s price chart.

INJ has moved at a snail’s pace in the past few weeks. The coin has lost just under 10% in its price value from last week and is currently trading at 15.97% less than its value a month ago. INJ investors are far from impressed by INJ’s decline, and they are now locked in for big profits on another project.

You might also like: SOL steadies, FET surges while Milei Moneda captivates investors

Cardano: Not showing bullish promises

ADA is among the top 10 altcoins in terms of market cap, and Cardano has experienced some growth in its TVL (Total Value Locked). However, the increasing interest in Cardano has not translated into any tangible growth for ADA investors’ portfolios.

Cardano has struggled to keep its head above the bearish waters in the past few days. ADA has maintained a 9.25% decline since last week, and its YTD is currently on a marginal 1.6% downtrend.

While ADA remains one of the top crypto coins by reputation, Cardano has been underachieving lately, and its Relative Strength Index (RSI) of 38.510 doesn’t exude much optimism. It Is a tough struggle between the bears and the bulls, and ADA investors have moved on to another project with a 100% ROI in two months.

Milei Moneda investors count their profits

Milei Moneda is a new meme coin that’s got everyone talking about its 100% ROI. Don’t get it twisted; the 100% ROI is not a forecast. The prices have been set, and the early investors stand the biggest chance of doubling their MEDA investments.

Milei Moneda has a large supply of 500,000,000 MEDA tokens, and the cryptocurrency ICO has implemented a deflationary system to deal with inflation and ensure MEDA’s growth is not stunted. 5%of every MEDA token will be burned after use, creating scarcity and pumping the token’s value.

Milei Moneda investors also have access to the DAO community of MEDA holders, where they can share ideas, participate in community activities, and win freebies.

Milei Moneda’s presale is still in Stage 1 of MEDA presale. The prices are set. MEDA is selling at $0.010 now, and you can bank on a 100% ROI when the project launches in May at $0.020 per token.

To learn more about this project, visit the Milei Moneda presale website or join the community

Disclosure: This content is provided by a third party. crypto.news does not endorse any product mentioned on this page. Users must do their own research before taking any actions related to the company.